Senior Pet Appetite Stimulants: Mirtazapine and Capromorelin

Why Appetite Stimulants Belong in Senior Care

Inappetence in senior pets is rarely a behavioral choice. It is almost always a symptom of an underlying problem: nausea from chronic kidney disease, chemotherapy-related GI effects, hepatic disease, cancer cachexia, post-surgical recovery, dental pain, sensory decline reducing food appeal, cognitive dysfunction disrupting feeding routines, or simply the cumulative effect of multiple chronic diseases. Addressing the underlying cause is always the first priority. But when the underlying issue cannot be quickly resolved, when treatment-related side effects persist, or when intake is failing to meet caloric needs despite dietary creativity, appetite stimulants enter the protocol as supportive tools.

The two mainstream appetite stimulants in veterinary medicine today are mirtazapine and capromorelin. Both are well-established. Both are vet-prescribed. Neither replaces underlying disease management; both make day-to-day management more workable when inappetence is otherwise compromising care. This article covers what each does, when each is chosen, and what owners realistically experience using them. Dosing is set by your prescribing vet based on weight, condition, and concurrent medications; we do not provide mg/kg numbers here.

Mirtazapine: Mechanism and Veterinary Use

Mirtazapine was originally developed as a human antidepressant. Its mechanism combines serotonergic and noradrenergic effects with potent antihistamine activity, and the appetite stimulation that emerged as a side effect in human use turned out to be remarkably useful in veterinary medicine. Cats in particular respond well to mirtazapine for appetite stimulation, and it also provides antiemetic effect against the nausea that often drives inappetence in CKD and chronic GI disease. The combination of appetite stimulation plus nausea control in a single medication makes it especially useful for cats whose inappetence stems from nausea more than from primary appetite loss.

Mirtazapine for cats is available in two main veterinary-relevant forms. Mirataz is the FDA-approved transdermal formulation specifically labeled for cats; the ointment is applied to the inner pinna and absorbs through the skin, sidestepping the pilling challenge that makes oral medications hard for many feline patients. Oral tablets (compounded or repurposed from human-grade tablets at vet-calculated doses) remain in use for cats who tolerate pilling and for dogs. Mirtazapine protocols for cats cover the feline-specific use cases in dedicated guidance.

Mirtazapine vs Cyproheptadine

Cyproheptadine is an older antihistamine with appetite-stimulating effects that was used in cats before mirtazapine became widely available. It remains in use for some cats, particularly when mirtazapine is contraindicated or not tolerated. The general clinical preference has shifted toward mirtazapine for most feline appetite stimulation needs because of its broader effect profile and dosing convenience, though cyproheptadine still has a role. Dedicated comparison resources cover mirtazapine versus cyproheptadine in cats.

Capromorelin: A Newer Mechanism

Capromorelin is a ghrelin-receptor agonist. Ghrelin is the body’s endogenous hunger hormone; activating its receptor triggers the central appetite response. Capromorelin is a veterinary-specific molecule developed by Elanco and approved by the FDA for dogs (Entyce, 2016) and later for cats (Elura, 2020). Unlike mirtazapine, capromorelin has minimal sedative, antiemetic, or behavioral effects; it works primarily on appetite. For pets where the issue is genuine appetite loss without prominent nausea, capromorelin may be the cleaner choice. For pets where nausea is part of the picture, mirtazapine often wins.

The Entyce for dogs article and parallel feline capromorelin coverage detail each formulation. Capromorelin is given as an oral solution, which makes administration easier than tablets in many situations. The dosing schedule is typically once-daily, though some protocols use different intervals; your vet sets the protocol.

When Each Medication Is Chosen

Selecting between mirtazapine and capromorelin (or sometimes using both, staggered or alternating) depends on the clinical picture. CKD cats with nausea-driven inappetence often start with mirtazapine because the antiemetic effect addresses two problems at once. Cancer pets facing chemotherapy-related inappetence may use either, depending on whether nausea or pure appetite loss dominates. Post-surgical recovery pets, especially those slow to resume voluntary eating, often respond to capromorelin’s targeted appetite stimulation. Hospice pets in late-stage inappetence may use either or both, prioritizing comfort and palatability over caloric targets.

Other appetite stimulants exist (corticosteroids have appetite-stimulating side effects but are rarely chosen primarily for that purpose; cyproheptadine remains in use; benzodiazepines were historically used in cats but largely abandoned for safety reasons). Mirtazapine and capromorelin are the modern mainstream because they have purpose-built profiles for veterinary appetite stimulation and acceptable safety records when used as directed.

Side Effects and What to Watch For

Mirtazapine side effects in cats can include vocalization, restlessness, and increased social attention (the medication sometimes produces a “talkative cat” effect that owners notice). Sedation can occur but is less common with appropriately dosed cat protocols. Serotonin-syndrome risk exists when mirtazapine is combined with other serotonergic medications (some SSRIs, TCAs, tramadol); your vet checks medication lists before prescribing. Capromorelin side effects are typically mild: occasional vomiting or diarrhea, transient salivation in some cats. Both medications have published safety data in the species they are labeled for.

Owners should report unexpected behavioral changes, persistent vomiting, signs of serotonin syndrome (restlessness, tremors, hyperthermia, GI signs), or any new concerns promptly to the prescribing vet. Adjustments to dose, schedule, or medication choice are common during the first weeks of appetite stimulant use as the team finds the right protocol for the individual pet.

Integration With Other Senior Nutrition Tools

Appetite stimulants work best as part of an integrated nutritional plan, not as standalone fixes. The right diet for the underlying condition (the renal diet, hepatic diet, cancer-managed nutrition, or specific protocol the pet is on) stays as the foundation. Multiple small meals make appetite stimulants more effective because more meal opportunities means more chances to convert stimulated hunger into intake. Antiemetic support (Cerenia / maropitant, ondansetron) pairs with appetite stimulants when nausea is a factor. Hydration support (fountains, wet food, broth, sub-Q fluids when indicated) runs parallel.

Hospice Use of Appetite Stimulants

In hospice care, appetite stimulants serve a different goal than in active disease management. The goal shifts from caloric targets to comfort and pleasure of eating. The hospice-specific appetite stimulant article covers the hospice framing in depth. Late-stage pets often need less food than younger or healthier ones; the question becomes whether the pet still finds eating pleasurable rather than whether they are meeting maintenance requirements. Appetite stimulants can keep eating a positive experience for longer, even when overall intake remains modest. Hospice nausea management with Cerenia and ondansetron pairs naturally with this framing.

Cost and Access Considerations

Both mirtazapine and capromorelin are vet-prescribed; capromorelin in particular has a veterinary-specific price point that reflects its proprietary status. Compounded mirtazapine can offer cost savings in some markets. Discuss cost-conscious options openly with the prescribing vet; many practices can adjust formulation, source, or frequency to fit budget constraints without abandoning the medication entirely. For cats specifically, transdermal Mirataz pricing has come down as the product has been on market longer; oral compounded mirtazapine remains a less-expensive option in many cases.

When to Stop, When to Continue

Appetite stimulants are typically not lifetime medications. Many pets use them through a defined treatment period (chemotherapy cycles, post-surgical recovery, acute CKD destabilization) and taper off as the underlying issue resolves or stabilizes. Others use them episodically, with intermittent courses through difficult periods separated by stretches without. Hospice pets may continue them until the end. The decision to continue, taper, or stop is collaborative with the prescribing vet based on the underlying disease trajectory, intake status, and the pet’s overall quality of life. Cancer-managed nutrition and renal management protocols both integrate appetite stimulants as needed.

Frequently Asked Questions

What is the difference between mirtazapine and capromorelin?

Mirtazapine is a serotonergic and antihistamine medication with appetite-stimulating and antiemetic effects. Capromorelin is a ghrelin-receptor agonist with primarily appetite-stimulating effect. Selection depends on whether nausea is part of the picture.

Can I give my pet an appetite stimulant without a vet visit?

No, both medications are prescription. Inappetence in a senior pet warrants a vet workup to identify the underlying cause before adding a stimulant; the cause may need treatment beyond appetite support.

Is Mirataz the same as oral mirtazapine?

Same active ingredient, different delivery. Mirataz is the FDA-approved transdermal ointment for cats; oral mirtazapine is the tablet form. Transdermal sidesteps the pilling problem in pill-averse cats.

How quickly do appetite stimulants work?

Most pets show response within hours to a few days of starting. If no response after a week of appropriate dosing, your vet may adjust dose, switch medications, or investigate other causes of inappetence.

Can my pet stay on appetite stimulants long-term?

Some pets use them continuously through chronic disease management; others use intermittent courses. Long-term use is appropriate when the underlying condition warrants it and your vet is monitoring for any concerns.